Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
21.51
+1.31 (6.49%)
Sep 16, 2025, 12:39 PM EDT - Market open
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.24 billion as of September 16, 2025. Its market cap has decreased by -44.95% in one year.
Market Cap
1.24B
Enterprise Value
427.86M
1-Year Change
-44.95%
Ranking
Category
Stock Price
$21.51
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.24B, an increase of 125.74%. That is a compound annual growth rate of 36.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.16B | -25.08% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |